Award

Nitric Oxide in Pulmonary Hypertension

Description: PROJECT NARRATIVE Pulmonary arterial hypertension (PAH) is a progressive and often lethal disease that disproportionately affects women. In this project, our goal is to discover the cellular metabolic mechanisms underlying the development and progression of PAH so that we can develop new strategies for treatment of patients.
Funding type: research
Funder scheme: R01
Start date: 1999-04-01
End date: 2025-12-31
Investigator: SERPIL C. ERZURUM
Institution: CLEVELAND CLINIC LERNER COM-CWRU
Funded outputs count: 91
Funder award ID: R01HL060917
OpenAlex ID: G7166330850
2025 · Weiling Xu, Kewal Asosingh, et al. · Blood Vessels Thrombosis & Hemostasis · 2
2025 · Weiling Xu, Kewal Asosingh, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
2024 · Samar Farha, Kewal Asosingh, et al. · Antioxidants and Redox Signaling · 4
2024 · Rebecca F. Hough, Cristina M. Alvira, et al. · American Journal of Respiratory Cell and Molecular Biology · 11
2023 · Michael V. Novotny, Weiling Xu, et al. · MethodsX · 8
2023 · Andrew Reichard, Nicholas Wanner, et al. · Cytometry Part A · 6
2023 · Yu Sun, Kate Stenson, et al. · Circulation Research · 10
2022 · Jason O. Robertson, Serpil C. Erzurum, et al. · American Journal of Respiratory Cell and Molecular Biology · 9
2022 · Kewal Asosingh, Matthew Frimel, et al. · American Journal of Respiratory Cell and Molecular Biology · 19
2021 · Jessica C. Sieren, Kimberly E. Schroeder, et al. · European Radiology · 4
2021 · Samar Farha, Suzy Comhair, et al. · Pulmonary Circulation · 14
2021 · Mehdi Baratchian, Jeffrey M. McManus, et al. · Scientific Reports · 116
2021 · Weiling Xu, Allison J. Janocha, et al. · Annual Review of Physiology · 190
Year
Topic